In a report released today, David Maris from Wells Fargo maintained a Hold rating on Perrigo Company plc (NYSE: PRGO), with a price target of $84. The company’s shares opened today at $72.60.
According to TipRanks.com, Maris is a 1-star analyst with an average return of -2.8% and a 43.4% success rate. Maris covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Emergent Biosolutions, and Flexion Therapeutics.
Perrigo Company plc has an analyst consensus of Moderate Buy, with a price target consensus of $99.75.
See today’s analyst top recommended stocks >>
The company has a one-year high of $95.93 and a one-year low of $63.68. Currently, Perrigo Company plc has an average volume of 1.14M.
Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PRGO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals.
